Simulations Plus Stock Price and Value Analysis

Should you buy Simulations Plus stock? (NasdaqCM:SLP). Let's see how it does in our automated value investing analysis system.

  • This company has fluctuating growth.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company has a low dividend yield.
  • This company is making money at a modest rate.

Inside the SLP Numbers

SLP Price
(Simulations Plus stock price per share)
[?] SLP Fair Price
(based on intrinsic value)
[?] SLP Safety Price (based on a variable margin of safety) $6.12
[?] PE Ratio versus Sector 255% higher than other Healthcare stocks
[?] PE Ratio versus Industry 7% higher than other Health Information Services stocks
[?] Cash Yield 0.91%
[?] Free Cash Flow Jitter 28%
[?] Dividend Yield 1%
Shares Shorted 1,603,687

Is Simulations Plus Stock on Sale?

We believe that Simulations Plus may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Simulations Plus looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy SLP Stock?

Does Simulations Plus have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.